Order results by:
| Issue | Title | |
| Vol 8, No 1 (2015) | PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION | Abstract similar documents |
| M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach | ||
| "... program of drug provision for patients suffering from 7 certain diseases and health states including organ ..." | ||
| Vol 9, No 3 (2016) | METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL | Abstract similar documents |
| O. V. Zhukova, S. V. Kononova | ||
| "... obstructive bronchitis in children. The original drug Augmentin (Smithkline Beecham Pharmaceuticals ..." | ||
| Vol 10, No 3 (2017) | Decision modelling for the evaluation of diabetes outcomes | Abstract similar documents |
| A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin | ||
| "... or to some aspects of the disease. Thus, the use of the novel anti-diabetic drugs (liraglutide, semaglutide ..." | ||
| Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
| M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
| "... in the costs of different drug therapy regimens. ..." | ||
| Vol 13, No 4 (2020) | Concept of value-based healthcare | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov | ||
| "... processes including procurement of drugs and medical devices, their pricing, and reimbursement. ..." | ||
| Vol 9, No 4 (2016) | THE COSTS OF REGIONAL ANESTHESIA WITH THE USE OF LEVOBUPIVACAINE, RACEMIC BUPIVACAINE AND ROPIVACAINE | Abstract similar documents |
| G. E. Ulrikh, A. V. Rudakova | ||
| "... of registration in the case of inclusion in the Essential Drugs List (0,5% R-R amp. 10 ml №10 – 947,74 RUB; 0 ..." | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| "... , national surveillance data, local health services market and cardiovascular drugs market estimation. “Cost ..." | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS | Abstract similar documents |
| O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina | ||
| "... . Adverse events and adverse drug reactions of GEBA were recorded regardless of the conditions of stay ..." | ||
| Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
| N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
| "... Perampanel (PER) is a novel drug for treatment of refractory partial epilepsy in patients≥12 y ..." | ||
| Vol 10, No 2 (2017) | CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES | Abstract similar documents |
| O. V. Zhukova, S. V. Kononova | ||
| "... between the original and generic drugs, and to evaluate the treatment of acute diseases. With respect ..." | ||
| Vol 11, No 3 (2018) | Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus | Abstract similar documents |
| A. G. Tolkushin, N. L. Pogudina | ||
| "... from analysis of published clinical and observational studies. The prices of the relevant drugs were ..." | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| "... . In the ocrelizumab group, the most common adverse events were caused by reactions to the drug infusion ..." | ||
| Vol 11, No 4 (2018) | Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach | Abstract similar documents |
| A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya | ||
| "... drugs). The possibility of analyzing indirect and non-medical costs is also discussed. A dynamic version ..." | ||
| Vol 12, No 2 (2019) | Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria | Abstract similar documents |
| S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
| "... the reference drug combinations (8 vs 18 days and 75% vs 34.8%, respectively, p=0.031). The cost of treatment ..." | ||
| Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
| N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
| "... and ribociclib that are included in Vital and Essential Drug List (VEDL) in combination with letrozole in first ..." | ||
| Vol 13, No 2 (2020) | Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation | Abstract similar documents |
| S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| "... will provide the purchase of additional modern drugs for patients. The cost-cutting reaches 12% for 5 years ..." | ||
| Vol 13, No 2 (2020) | A modern conception of postcholecystectomy syndrome (based on the materials of the Advisory Board held on May 4, 2019 in Almaty, Kazakhstan) | Abstract similar documents |
| A. V. Nersesov, D. A. Kaibullaeva, O. S. Vasnev, L. K. Tashenova, M. M. Sakhipov, G. T. Berestimov, G. A. Akhmetzhanova, O. T. Ibekenov, M. O. Doskhanov, N. M. Zhumazhanov, Zh. M. Balzhanov, B. A. Aitmoldin, E. A. Toleubaev, E. M. Laryushina, K. N. Zhumagulov, G. N. Sobirova, S. I. Umarova, Yu. O. Shulpekova, A. V. Okhlobystin | ||
| "... -inflammatory drugs, prokinetics, nitrates, antispasmodics, calcium channel antagonists, botulinum toxin ..." | ||
| Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
| "... of the CG drug in OA). The effectiveness of therapy was assessed using the VAS, Lequesne, WOMAC scales ..." | ||
| Vol 13, No 4 (2020) | Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system | Abstract similar documents |
| T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky | ||
| "... criteria for the reimbursement of medical technologies, including medicinal drugs. ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia | Abstract similar documents |
| I. A. Metelkin, R. I. Yagudina | ||
| "... costs were taken into account: expenses for drug therapy, hospitalization (intensive care unit ..." | ||
| Vol 13, No 3 (2020) | Economic burden of systemic sclerosis: systematic review | Abstract similar documents |
| D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin | ||
| "... by direct medical costs for hospitalization and drug therapy and indirect costs were mostly associated ..." | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| "... were compiled into the model. The authors accounted for direct medical (diagnostics, drugs, surgery ..." | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| "... .3%), hypoglycemic – 457/2450 (18.7%) drugs. Lipotropic products administered at 319/2450 (13.0%) cases, detoxifying ..." | ||
| 101 - 123 of 123 Items | << < 1 2 3 | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
